Telomere Length and Endometrial Cancer
Telomere Length and Endometrial Cancer
批准号:
7501323
负责人:
Immaculata De Vivo
金额:
$8.75万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-27 至 2010-08-31
关键词:
Adenocarcinoma CellAgeBiological MarkersBody mass indexCell LineChronic DiseaseEndometrialEndometrial CarcinomaEpithelialEstrogensExposure toFrequenciesGenesGeneticGenetic PolymorphismGenotypeHaplotypesLengthLeukocytesLife StyleMalignant NeoplasmsMeasuresModelingNeoplasmsNested Case-Control StudyNurses&apos Health StudyRiskRisk MarkerTERF1 geneTERT geneTelomeraseTelomere ShorteningVariantWomen&aposs Healthcancer riskcase controlcigarette smokinghuman TERT proteinperipheral bloodprospectivetelomerase reverse transcriptasetelomere
中文摘要
描述(由申请人提供):
在外周血白细胞(PBL)中测量的端粒长度已成为慢性疾病如癌症风险的主要生物标志物。我们建议在两项大型巢式病例对照研究(护士健康研究和妇女健康研究)中调查PBL中端粒长度与子宫内膜癌风险之间的关系。我们还希望确定子宫内膜癌的风险是否受到端粒稳定性相关基因(如编码端粒酶催化亚基的hTERT)多态性的影响。此外,我们希望评估端粒长度的环境和生活方式决定因素,这些因素可以被修改以降低子宫内膜癌的风险。子宫内膜癌主要是由游离雌激素的终生暴露决定的,并且是其他子宫决定的癌症的相关模型。因此,建立外周血淋巴细胞端粒长度和子宫内膜癌之间的关系将提供一个更好的了解子宫内膜驱动的肿瘤的机制。我们对端粒长度的前瞻性测定将特别重要,既可以确认端粒长度作为风险标志物的价值,也可以了解生活方式因素如何直接影响端粒缩短,从而降低子宫内膜癌的风险。
英文摘要
DESCRIPTION (provided by applicant):
Telomere length measured in peripheral blood leucocytes (PBLs) has emerged as a principal biomarker for risk of chronic diseases such as cancer. We propose to investigate the association between telomere length in PBLs and risk of endometrial cancer in two large nested case-control studies, the Nurses' Health Study and the Women's Health Study. We also wish to determine whether the risk of endometrial cancer is influenced by polymorphisms in telomere-stability related genes such as hTERT that encodes the catalytic subunit of telomerase. Additionally, we wish to assess environmental and lifestyle determinants of telomere length that can be modified to reduce risk of endometrial cancer. Endometrial cancer is primarily determined by total lifetime exposure to free- estrogens and is a pertinent model for other hormonally determined cancer. Therefore, establishing a relationship between telomere length in PBLs and endometrial cancer would provide a greater understanding of the mechanisms involved in the hormonally driven neoplasia. Our prospective determination of telomere length would be particularly important, both for confirming the value of telomere length as a risk marker, as well as for understanding how lifestyle factors directly impact telomere shortening, and thus might reduce risk of endometrial cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comprehensive molecular characterization of endometrial cancer, etiologic heterogeneity, and racial disparities
-
批准号:10156374
-
项目类别:
-
资助金额:$112.51万
-
财政年份:2021
-
负责人:Immaculata De Vivo
-
依托单位:
Comprehensive molecular characterization of endometrial cancer, etiologic heterogeneity, and racial disparities
-
批准号:10579194
-
项目类别:
-
资助金额:$106.08万
-
财政年份:2021
-
负责人:Immaculata De Vivo
-
依托单位:
Comprehensive molecular characterization of endometrial cancer, etiologic heterogeneity, and racial disparities
-
批准号:10343822
-
项目类别:
-
资助金额:$104.67万
-
财政年份:2021
-
负责人:Immaculata De Vivo
-
依托单位:
Advances in Endometrial Cancer Epidemiology and Biology
-
批准号:8720267
-
项目类别:
-
资助金额:$3.11万
-
财政年份:2014
-
负责人:Immaculata De Vivo
-
依托单位:
Genome-Wide Association Study of Endometrial Cancer
-
批准号:7725761
-
项目类别:
-
资助金额:$216.79万
-
财政年份:2009
-
负责人:Immaculata De Vivo
-
依托单位:
Telomere Length and Endometrial Cancer
-
批准号:7389056
-
项目类别:
-
资助金额:$8.75万
-
财政年份:2007
-
负责人:Immaculata De Vivo
-
依托单位:
Genome Wide Association Study: Variants Influencing Steroid Hormone Levels
-
批准号:7501343
-
项目类别:
-
资助金额:$8.75万
-
财政年份:2007
-
负责人:Immaculata De Vivo
-
依托单位:
Whole genome amplification and DNA pooling strategies
-
批准号:6650468
-
项目类别:
-
资助金额:$8.17万
-
财政年份:2003
-
负责人:Immaculata De Vivo
-
依托单位:
Whole genome amplification and DNA pooling strategies
-
批准号:6751155
-
项目类别:
-
资助金额:$8.2万
-
财政年份:2003
-
负责人:Immaculata De Vivo
-
依托单位:
GENETIC SUSCEPTIBILITY TO ENDOMETRIAL CANCER
-
批准号:6174099
-
项目类别:
-
资助金额:$29.44万
-
财政年份:1999
-
负责人:Immaculata De Vivo
-
依托单位:
GENETIC SUSCEPTIBILITY TO ENDOMETRIAL CANCER
-
批准号:6377432
-
项目类别:
-
资助金额:$31.11万
-
财政年份:1999
-
负责人:Immaculata De Vivo
-
依托单位:
GENETIC SUSCEPTIBILITY TO ENDOMETRIAL CANCER
-
批准号:6633497
-
项目类别:
-
资助金额:$33.01万
-
财政年份:1999
-
负责人:Immaculata De Vivo
-
依托单位:
GENETIC SUSCEPTIBILITY TO ENDOMETRIAL CANCER
-
批准号:6514154
-
项目类别:
-
资助金额:$32.05万
-
财政年份:1999
-
负责人:Immaculata De Vivo
-
依托单位:
Genetic Susceptibility to Endometrial Cancer
-
批准号:7238538
-
项目类别:
-
资助金额:$33.18万
-
财政年份:1999
-
负责人:Immaculata De Vivo
-
依托单位:
Molecular Pathoepidemiology of Endometrial Cancer Risk
-
批准号:8831602
-
项目类别:
-
资助金额:$43.1万
-
财政年份:1999
-
负责人:Immaculata De Vivo
-
依托单位:
Genetic Susceptibility to Endometrial Cancer
-
批准号:6979284
-
项目类别:
-
资助金额:$34.47万
-
财政年份:1999
-
负责人:Immaculata De Vivo
-
依托单位:
Molecular Pathoepidemiology of Endometrial Cancer Risk
-
批准号:8235395
-
项目类别:
-
资助金额:$35.97万
-
财政年份:1999
-
负责人:Immaculata De Vivo
-
依托单位:
Genetic Susceptibility to Endometrial Cancer
-
批准号:7117317
-
项目类别:
-
资助金额:$34.05万
-
财政年份:1999
-
负责人:Immaculata De Vivo
-
依托单位:
Genetic Susceptibility to Endometrial Cancer
-
批准号:7497862
-
项目类别:
-
资助金额:$32.55万
-
财政年份:1999
-
负责人:Immaculata De Vivo
-
依托单位:
Molecular Pathoepidemiology of Endometrial Cancer Risk
-
批准号:8450743
-
项目类别:
-
资助金额:$40.35万
-
财政年份:1999
-
负责人:Immaculata De Vivo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: